WASF3 and prostate carcinoma: When DU145 clone 4, which shows limited knockdown of WASF3, was compared with clones 8 and 14, which show extensive knockdown, a clear reduction in wound-healing capability was noted in the knockdown cells (Figure 3), further supporting the relationship between WASF3 expression and cell motility in prostate cancer cells.